Efficacy of Zinc in the Treatment of Pneumonia
This study is designed to evaluate the efficacy of zinc supplementation in the treatment of children under the age of two years who have been hospitalized with severe pneumonia.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
|Official Title:||Efficacy of Zinc in the Treatment of Pneumonia in Hospitalized Children Less Than 2 Years of Age|
- Duration of severe symptoms [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- Time to recovery from severe pneumonia [ Time Frame: 2 years ] [ Designated as safety issue: No ]
|Study Start Date:||September 2003|
|Study Completion Date:||August 2004|
|Primary Completion Date:||August 2004 (Final data collection date for primary outcome measure)|
Children with severe pneumonia were randomly assigned to receive supplementation with elemental zinc.
Other Name: Zinc
No Intervention: Control
Children with severe pneumonia were randomly assigned to receive supplementation with placebo tablets.
This study was a randomized, double-blind, placebo-controlled clinical trial conducted between September 2003 and August 2004 at the Christian Medical College (CMC) Hospital in Vellore, India. CMC Hospital is a large teaching hospital and medical center that is accessed directly by the population of Vellore and adjoining districts and by referrals from local medical practitioners.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00198666
|Principal Investigator:||Mathuram Santosham, MD||Johns Hopkins Bloomberg School of Public Health|